Posts

Subscribe Now!

Sequent Scientific Ltd. - A Pure-Play Animal Healthcare Business

Image
Sequent Scientific Limited - Company Overview Twitter Handle: @s huchi_nahar Link to Animal Healthcare Related Articles: https://myweekendspot.blogspot.com/2020/08/animal-health-care-industry-future-ahead.html 1) Company Profile Incorporated in 1985, Sequent Scientific Ltd (SSL) undertakes its animal health business under the aegis of Alivira Animal Health Limited, which is engaged in manufacturing veterinary APIs and formulations. Earlier SSL was engaged in the manufacturing human APIs, which has been de-merged with effect from October, 2017. Alivira Animal Health Limited has emerged as India's largest and 1st Global integrated animal health company specialising in manufacturing of Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF). Sequent is India’s first integrated, global animal health company with an annual revenue run-rate of US$ 150 million. It offers API, branded generic formulations and analytical services. Over the past four years, compa

Syngene - Next Giant Player for CDMO

Image
  Syngene International Limited -  Company Overview Twitter Handle: @shuchi_nahar Link to FY 2020-21 Annual Report takeaways - https://myweekendspot.blogspot.com/2021/10/syngene-international-ltd-fy2020-21.html 1. Company Overview Incorporated in 1994 as a subsidiary of Biocon, Syngene International (SIL) is a leading contract research organization (CRO), which supports R&D programs of global innovative companies   SIL offers outsourced services to support discovery and development for organizations across industrial sectors like pharmaceuticals, biopharmaceuticals, nutraceuticals, animal health, agro-chemicals, etc. It currently caters to 293 global players including Bristol-Myers Squibb (BMS), Abbott, Baxter and Amgen, among others. SIL derives 95% of its revenues from exports. Mangalore API plant is constructed and validation is expected to be completed in FY21.  In FY20, Syngene extended its biologics discovery and preclinical research capabilities in CAR-T therapy,

Hikal – An Unique CDMO Opportunities for Pharmaceutical, Animal Healthcare & Crop Protection

Image
  Hikal – Company Overview Shuchi.P.Nahar Twitter: @shuchi_nahar Link to my previous blog for detail explanation on  What are CDMO and their wide scope: 1 .  https://myweekendspot.blogspot.com /2020/07/ what-is-so-attractive-about-cdmos-in.html   2 .  https://myweekendspot.blogspot.com /2020/07/a-masterclass-on-global-custom.html 1.  Company Overview Established in 1988, Hikal is predominantly a B2B player that provides intermediates and active ingredients to global pharmaceutical, animal health, crop protection and specialty chemical companies. Hikal today is one of the leading global suppliers to the Life Sciences industry. Company is having six sites providing a multitude of services across the value chain. Figure:1 Business Snapshot The pharma business is currently divided almost equally between generic active pharma ingredients (APIs) and contract development and manufacturing organisation (CDMO) businesses. Leading Sustainable Technology driven company serving the Crop Protecti